| ABIOMED develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and end-organs and/or temporarily assisting the pumping function of the heart. Co.'s products include: Impella 2.5®, which is a percutaneous micro heart pump with an integrated motor and sensors; Impella CP®, which provides more blood flow than the Impella 2.5; Impella RP®, which is a percutaneous catheter-based axial flow pump; and Impella Connect®, which is a cloud-based technology that enables remote viewing of the Automated Impella Controller for physicians and hospital staff from anywhere with internet connectivity. We show 46 historical shares outstanding datapoints in our coverage of ABMD's shares outstanding history.|
Understanding the changing numbers of ABMD shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like ABMD versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching ABMD by allowing them to research ABMD shares outstanding history
as well as any other stock in our coverage universe.